Angola vs Mauritania: Cause of death, by non-communicable diseases, ages 60+, female
Angola
69.6%
in 2021
Mauritania
69.6%
in 2021
Angola rank
125th
Mauritania rank
124th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Angola
- Mauritania
How they compare
Mauritania currently reports 69.6% against 69.6% in Angola, a difference of 0.0%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Angola ahead.
Angola ranks 125th and Mauritania ranks 124th of 185 countries.
Across the 3 decades both report, Angola averaged higher in 2 and Mauritania in 1.
Head to head by decade
| Decade | Angola | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 68.6% | 67.9% | 0.6% | Angola |
| 2010s | 72.0% | 75.6% | 3.5% | Mauritania |
| 2020s | 71.8% | 70.3% | 1.6% | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Angola or Mauritania?
- Mauritania, at 69.6% against 69.6% in Angola as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Angola and Mauritania?
- 0.0%, with Mauritania ahead.
- How many years of comparable data are there for Angola and Mauritania?
- 6 years are reported by both, from 2000 to 2021.
- How do Angola and Mauritania rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Angola ranks 125th and Mauritania ranks 124th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.